Gustave Roussy Foundation - CRIS cancer Foundation
Clinical Scientist Emerging Leader Programme
Position acceptance
Beneficiaries must accept their position on the programme between 1 April and 30 June 2025. Under duly justified circumstances, their incorporation may be delayed until 31 September 2025. The start date must be communicated to Gustave Roussy Foundation and CRIS Cancer prior to that date. In duly justified cases of major force, this incorporation could be postponed. Each case will be assessed by GRF and CRIS cancer on an individual basis. GRF and CRIS cancer reserves the right to move the position or even leave it vacant if the beneficiaries do not meet the requirements for incorporation or the time until incorporation is too long.
Call for Applications
In 2025, Gustave Roussy Foundation and CRIS Cancer haved runned the first GRF-CRIS Clinical Scientist Emerging Leader Programme call, to award 1 research grant, covering a threeyear period, for the purposes of incentive clinical scientists to develop their career at the Gustave Roussy Institute.
The call for applications has closed on 28 February 2025 at 23:59 (Central European Time - CET).
Candidates’ clinical practice workload may not exceed 50% of their working day. The candidate does not necessarily need to be employed by the Gustave Roussy Institute at the time of application. However, the Gustave Roussy Institute must indicate in a letter that it accepts the candidate to carry out his or her activities there.
More about the next call for applications RLtrials@gustaveroussy.fr
To find out more, download the documents below:
Clinical Scientist Emerging Leader Programme - Presentation- Research Project
- Gustave Roussy Institute Acceptance Letter
- Budget
- Statement on Ethical Issues
